Selman Unal, MD FEBU FECSM

Meet the Editor: Murat Gul, MD — Associate Editor, IJIR. Assistant Professor (Selcuk University, Urology); post-doc andrology fellowship at University of Copenhagen / Juliane Marie Centre (Rigshospitalet). @docctoore @selcukuniresmi @Rigshospitalet @koebenhavns_uni #IJIR

Hayatımda bu kadar saçma bir argüman görmedim. 100 haneli mahalleye de 10 tane minibüs yeter. Herkes otomobilini satsın, 10 minibüs alıp hayatına öyle devam etsin insanlar?

@drcetiner Peki şehirde ulaşım için kaç özel araç gerekli ve hane başına kaç özel araç mevcut?

Peki köydeki tüm araziyi sürmek için en fazla kaç traktöre ihtiyaç vardır? Kaç tane traktör yeterlidir?

Men with a total motile sperm count of >120 million could expect to live 2.7 years longer than men with total motile sperm count of >0–5 million. #semenquality #testicularfunction #lifespan #survival #mortality share.google/bxh4fpmccnE4Bk…

Zenginler şöyle insanlar kardeşim, senin köyün var hayvanın ağacın doğayla bütünleşiksin bu geliyor oraya maden açıyor her şeyi katlediyor sen aç kalmamak için o madende çalışıp ölüyorsun, o da oradan kazandığı parayla sağa sola gidip bu goygoyu yapıyor.

GLP-1 receptor agonists and male sexual health: Translating cardiometabolic benefits into erectile outcomes 👉 rdcu.be/e9h5m @faucollegeofmed

Efficacy of D-Mannose Monotherapy vs. Other Agents in Preventing Recurrent Urinary Tract Infections in Women: A Systematic Review and Meta-Analysis Ahmed Al-Hajjaj et al. Link : urologyresearchandpractice.org/index.php/pub/…

#EAU highlight: Leonidas Karapanos, MD, presented IPP placement with modified Egydio TEP for severe penile curvature in Peyronie’s disease with concomitant ED. More on this technique: nature.com/articles/s4144… @LeonKarapanos @Uroweb @klinikumleverkusen #PeyroniesDisease #Andrology

We’ve trained a multimodal AI model to turn routine pathology slides into spatial proteomics, with the potential to reduce time and cost while expanding access to cancer care.

Every time you get a cancer biopsy, the lab makes a tissue slide that costs about $5. It shows the shape of your cells under a microscope, and every cancer patient already has one on file. There’s a much fancier version of that test called multiplex immunofluorescence (basically a protein-level map showing which immune cells are near your tumor and what they’re doing). It costs thousands of dollars per sample, takes specialized equipment most hospitals don’t have, and barely scales. But it’s the kind of data oncologists need to figure out whether immunotherapy will actually work for you. Right now, only about 20 to 40% of cancer patients respond to immunotherapy, and one of the biggest reasons is that doctors can’t easily tell whether a tumor is “hot” (immune cells actively fighting it) or “cold” (immune system ignoring it). Microsoft, Providence Health, and the University of Washington trained an AI to analyze the $5 slide and predict what the expensive test would show across 21 different protein markers. They called it GigaTIME, trained it on 40 million cells in which both the cheap slide and the expensive test coexisted, and then turned it loose on 14,256 real cancer patients across 51 hospitals in 7 US states. The results landed in Cell, one of the most selective journals in biology. The model generated about 300,000 virtual protein maps covering 24 cancer types and 306 subtypes. It found 1,234 real, verified connections between immune cell behavior, genetic mutations, tumor staging, and patient survival that were previously invisible at this scale. When they tested it against a completely separate database of 10,200 cancer patients, the results matched up almost perfectly (0.88 out of 1.0 agreement). Nature Methods named spatial proteomics (mapping where specific proteins sit inside your tissue) its Method of the Year in 2024, and specifically cited GigaTIME in a March 2026 update as a model that “democratizes” this kind of analysis. The full model is open-source on Hugging Face. Any cancer research lab with archived biopsy slides, and most of them have thousands, can now run virtual immune profiling without buying a single piece of new equipment.

👏 Congratulations to Andrea Sansone, MD, PhD (University of Rome Tor Vergata @unitorvergata2) — IJIR Reviewer of the Month (March 2026). Thank you for helping uphold rigorous peer review in sexual medicine. Interested in reviewing for IJIR? nature.com/ijir/authors-a…

Delighted to share our new paper on the effects of commonly used overactive bladder medications on #erectilefunction is published in Sexual Medicine Reviews. Special thanks to @drserefoglu for the guidance and mentorship 👉🏼 bit.ly/4brxlPb @sexmedjournals @essm_tweets

It is here! The #Urology book. It is a very practicado manuscript for health proffesionals. Thank you @Panamericanaesp for trusting me. Finally thank to all the authors, amazing work

The new ESSM webinar series “Legends of Sexual Medicine” starts Monday. First speaker: Irwin Goldstein Topic: My Way in Sexual Medicine 🗓 9 March 2026 🕗 20:00–21:00 CET Register: bit.ly/4aRp3jB #ESSM #sexualmedicine

Prof. Dr. Ege Can Şerefoğlu, Avrupa Cinsel Tıp Derneği (ESSM) Bilimsel Komite Başkanlığı’na Seçildi Cinsel tıp alanında Avrupa’nın en saygın bilimsel kuruluşlarından biri olan Avrupa Cinsel Tıp Derneği (European Society for Sexual Medicine – ESSM) Bilimsel Komite Başkanlığı görevine Tıp Fakültesi Üroloji Anabilim Dalı Öğretim Üyemiz Prof. Dr. Ege Can Şerefoğlu seçildi. 2009 yılından bu yana ESSM üyesi olan ve uzun yıllardır derneğin çeşitli bilimsel ve idari kademelerinde aktif görev alan Prof. Dr. Şerefoğlu, son olarak Yönetim Kurulu (Executive Committee) üyesi olarak görev yapmaktaydı. Yeni görevinde ESSM’nin bilimsel stratejisinin belirlenmesi, kongre ve eğitim programlarının akademik içeriğinin oluşturulması ve uluslararası bilimsel standartların korunmasından sorumlu olacak. Konuyla ilgili açıklamasında Prof. Dr. Şerefoğlu şunları söyledi: “20 yılı aşkın süredir cinsel sağlık alanında yürüttüğüm çalışmaların neticesinde ESSM Bilimsel Komite Başkanlığı görevine seçilmek benim için büyük bir onur ve sorumluluk oldu. Bundan önce olduğu gibi, bundan sonra da amacım bilimsel şeffaflık, akademik bağımsızlık ve uluslararası iş birliğini ön planda tutarak derneğimizin bilimsel gücünü daha da ileri taşımaktır.”

INTERNATIONAL MASTERCLASS IN PENILE RECONSTRUCTIVE SURGERY – THIRD EDITION We are proud to gather once again for the third edition of the International Masterclass in Penile Reconstructive Surgery — an advanced, practice-oriented educational program that combines academic knowledge with real-life surgical experience. This comprehensive masterclass will cover advanced penile prosthetic surgery, complex Peyronie’s disease correction, penile length, girth and shape reconstruction, as well as adjunctive and emerging techniques. Participants will gain not only theoretical insights but also advanced perspectives on surgical strategy, patient selection, and complication management. With distinguished international faculty and participants, this scientific meeting aims to present the contemporary approach to modern penile reconstructive surgery through a multidisciplinary lens. @drserefoglu @drMarcoFalcone1 📅 June 6, 2026 📍 Biruni University – Istanbul, TURKEY Seats are limited. For detailed information and registration, please contact us. #PenileReconstructiveSurgery #PenileProsthesis #PeyroniesDisease #Andrology #Urology #Masterclass #SurgicalEducation #ReconstructiveUrology #IstanbulMedical

Bedtime #sildenafil oral suspension improves sexual spontaneity and time-concerns compared to on-demand treatment in men with #erectiledysfunction. @ManuelAlonsoUro is sharing data from @yoursexmedjour article during #WMSM2026. To read the full text 👉🏻 rdcu.be/e5ZJT

WMSM26 e-poster: Remaining teeth, periodontal disease & occlusal support status vs erectile dysfunction — Naoki Fujita (Japan, @hirosaki_univ) @essm_tweets #WMSM26 #ED #Andrology #Urology #OralHealth #PeriodontalDisease #ClinicalResearch

During #WMSM2026 meeting, Dimitris Hatzichristou summarized his 3T technique which will soon be published in @yoursexmedjour . Stay tuned 😉

The SMSNA session at #WMSM26 was a success, featuring presentations from members of our Board. Attendees enjoyed two debates on TRT, in-depth case reviews, & the latest updates on hypogonadism treatment options. Thank you to our outstanding faculty and to everyone who joined us!